KYNB

$4.31-3.36%visit website

KYNTRA BIO, INC.

Market Cap

$17M

Live price × SEC shares (Jul 31, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.07

60mo monthly vs SPY

P/E (TTM)

0.1

TTM to Jun 2026 · diluted EPS

P/S (TTM)

3.8

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	1,076	1,277	3,738	(1,474)	4,617
Cost of revenue	(58)	278	4,106	2	4,328
Research & development	1,209	7,268	7,566	6,821	22,864
Selling, general & administrative	5,295	7,250	5,862	9,266	27,673
Operating income	(5,411)	(13,512)	(13,818)	(17,574)	(50,315)
Interest expense	2,083	2,413	2,427	2,368	9,291
Pretax income	(13,146)	(14,610)	(15,132)	11,973	(30,915)
Income tax	0.00	0.00	0.00	(1.00)	(1.00)
Net income	200,636	(14,220)	(15,198)	11,974	183,192
EPS (basic) ($)	49.61		(3.76)	2.96	45.30
EPS (diluted) ($)	49.61		(3.76)	2.96	45.30
Weighted avg. shares (basic)	4,044		4,047	4,048
Weighted avg. shares (diluted)	4,044		4,047	4,048

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 46 more quarters, back to Mar 2014, with Tormere Pro.

Corporate Events (8-K)

12 filings in 12 months · 2 with priority itemsFull history →

Filed	Items	Filing
Oct 6, 2026 accepted 8:05 PM ET	3.01Delisting notice	Document SEC ↗
Oct 1, 2026 accepted 11:30 AM ET	5.02Officer / director change	Document SEC ↗
Aug 31, 2026 accepted 9:18 PM ET	1.01Material agreement2.03New debt obligation7.01Reg FD disclosure	Document SEC ↗
Aug 13, 2026 accepted 8:05 PM ET	2.02Earnings release	Document SEC ↗
Jun 16, 2026 accepted 11:23 PM ET	5.07Shareholder vote	Document SEC ↗
Jun 9, 2026 accepted 9:04 PM ET	8.01Other events	Document SEC ↗
May 11, 2026 accepted 8:05 PM ET	2.02Earnings release	Document SEC ↗
Apr 9, 2026 accepted 8:10 PM ET	3.01Delisting notice	Document SEC ↗
Mar 16, 2026 accepted 8:05 PM ET	2.02Earnings release	Document SEC ↗
Jan 7, 2026 accepted 9:15 PM ET	5.03Bylaws / fiscal year8.01Other events	Document SEC ↗